Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system, in the context of tolerance induction to *Ambrosia artemisiifolia* allergens, refers to the network of cells and molecular pathways that can be modulated to reduce or eliminate allergic responses through immunological tolerance. This process is central to allergen immunotherapy (AIT), which aims to desensitize individuals who are allergic to ragweed pollen by shifting their immune response from a pathogenic, allergy-promoting state toward a tolerant, non-reactive state. Key mechanisms involve the shift from Th2 dominance to Treg-mediated regulation, increased production of blocking antibodies (IgG4), and decreased IgE responses to Amb a 1, the major ragweed allergen.
Shift from Th2-mediated allergy to regulatory/tolerant profile through repeated exposure to allergen extracts leading to increased Treg activity, blocking antibody production (IgG4), and reduced IgE response.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Induction of Tolerance to Ambrosia artemisiifolia Allergens) (N/A).